Monday, October 3, 2022

561.316.3330

Biotechnology News Magazine

$2 Billion Worldwide Contrast Media Injectors Industry to 2027 – Featuring Bayer, Bracco Imaging and General Electric Among Others

Latest Posts

City of Hope to Accelerate Immunotherapy Research & Treatment Innovation with $15 Mil Gift from Ted Schwartz Family

Ted Schwartz, who is now cancer free, achieved complete remission at City of Hope in 2020 with the center's leading CAR T cell therapy after a 16-year battle with lymphoma, provided the gift to City of Hope to advance treatment options that offer better outcomes and quality of life for people living with cancer.

Neurocrine Biosciences Appoints Dr Ingrid Delaet as Chief Regulatory Officer

Prior to joining Neurocrine Biosciences, Dr Ingrid Delaet served as Senior Vice President, Regulatory Affairs at Intercept Pharmaceuticals, which she joined in 2016.

Astrea Bioseparations Introduces Nereus LentiHERO, a Fit-for-purpose Solution for Lentiviral Vector Purification

“We believe that AstreAdept will be a game-changer,” explained Astrea Bioseparations’ CEO Terry Pizzie. “Our approach was to rapidly develop and incorporate this material into the Nereus LentiHERO, a simple, fit-for-purpose device that radically transforms how lentivirus can be purified [in terms of speed, recovery, and efficiency].

At Pack Expo, Schreiner MediPharm to Debut Functional Labels Designed from More Sustainable Materials

Schreiner MediPharm advises he new label concepts are based on existing items in Schreiner MediPharm’s roster of functional labeling solutions.

The “Contrast Media Injectors Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering.

The global contrast media injectors market reached a value of US$ 1.46 Billion in 2021. Looking forward, the publisher expects the market to reach a value of US$ 2.16 Billion by 2027, exhibiting a CAGR of 6.75% during 2021-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Contrast media injectors are medical devices utilized to inject contrast media into the body for enhancing the visibility of tissues for different medical imaging procedures. These procedures include computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET) or magnetic resonance.

Contrast media injectors find extensive applications in radiology, interventional cardiology, ambulatory surgical centers (ASCs), and diagnostic imaging centers across the globe. At present, they have evolved from simple, manual injectors to automated injectors that precisely control the amount of the contrast media agent used, facilitate automated data collection, and warn about potential hazards, such as air embolisms or extravasations.

Increasing preferences for minimally invasive (MI) medical procedures that offer numerous benefits, such as smaller incisions, less postoperative pain, faster recovery, and shorter hospital stay, represents one of the key factors bolstering the growth of the market.

Moreover, there is a rise in the use of automated contrast media injectors in cardiac imaging to help enhance patient safety and improve image quality. Besides this, leading players are focusing on offering personalized contract media doses to patients using information from an electronic medical record (EMR) or picture archiving and communication system (PACS).

This, coupled with the emergence of syringeless power injectors, which aid in reducing contrast media waste, is facilitating the growth of the market. Apart from this, there is a widespread prevalence of cancers, including breast, lung, colon, rectum, and prostate cancers, around the world. This, along with the increasing number of regulatory approvals of contrast agents and the significant growth in the healthcare industry, is projected to create a positive outlook for the market in the upcoming years.

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being APOLLO RT Co. Ltd., Bayer AG, Bracco Imaging S.p.A., General Electric Company, Guerbet, Medtron AG, Nemoto Kyorindo Co. Ltd., Shenzhen Anke High-tech Co. Ltd., Shenzhen Seacrown Electromechanical Co. Ltd., Sino Medical-Device Technology Co. Ltd. and ulrich GmbH & Co. KG.

Key Questions Answered in This Report:

  • How has the global contrast media injectors market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global contrast media injectors market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the injectors type?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global contrast media injectors market and who are the key players?
  • What is the degree of competition in the industry?

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Contrast Media Injectors Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product Type
6.1 Consumables
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Syringes
6.1.2.2 Tubes
6.1.2.3 Others
6.1.3 Market Forecast
6.2 Injector Systems
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 CT Injectors
6.2.2.2 MRI Injectors
6.2.2.3 Angiography Injectors
6.2.2.4 Accessories
6.2.3 Market Forecast

7 Market Breakup by Injectors Type
7.1 Single-head Injectors
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Dual-head Injectors
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Syringeless Injectors
7.3.1 Market Trends
7.3.2 Market Forecast

8 Market Breakup by Application
8.1 Radiology
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Interventional Cardiology
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Interventional Radiology
8.3.1 Market Trends
8.3.2 Market Forecast

9 Market Breakup by End User
9.1 Hospitals
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Ambulatory Surgery Centers
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Diagnostics Imaging Centers
9.3.1 Market Trends
9.3.2 Market Forecast

10 Market Breakup by Region

11 SWOT Analysis

12 Value Chain Analysis

13 Porters Five Forces Analysis

14 Price Analysis

15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 APOLLO RT Co. Ltd.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.2 Bayer AG
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Bracco Imaging S.p.A.
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.4 General Electric Company
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Guerbet
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 Medtron AG
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 Nemoto Kyorindo Co. Ltd.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.8 Shenzhen Anke High-tech Co. Ltd.
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.9 Shenzhen Seacrown Electromechanical Co. Ltd.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.10 Sino Medical-Device Technology Co. Ltd.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.11 ulrich GmbH & Co. KG
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio

For more information about this report visit here.

Latest Posts

Learn More

spot_img

Subscribe

spot_img

Our Sister Publication

Medical Device News Magazine